The DOI matches its Crossref record; 3 of the 3 references it cites were found in a registry or an index.
Intravenous N-Acetylcysteine Improves Transplant-Free Survival in Early Stage Non-Acetaminophen Acute Liver Failure
Overview
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Run the check — free, no account needed. It reads the open-access text and checks the sources it cites.
Claims other papers make about this one
Each is checked against this paper’s own text: does it say what the citing paper says it does?
In a randomized placebo-controlled trial of adult non-APAP acute liver failure (including DILI as the etiology), intravenous N-acetylcysteine improved transplant-free survival in early stage acute liver failure with grade I-II coma.
“In a randomized placebo-controlled trial of adult non-APAP ALF (including DILI as the etiology), intravenous NAC improved transplant-free survival in early stage ALF with grade I-II coma [185].”
From Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update (2024) · cites this paper as [185]
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Early indicators of prognosis in fulminant hepatic failure
O'Grady, J. G., Alexander, G. J. M., Hayllar, K. M., & Williams, R. (1989) · Gastroenterology · doi:10.1016/0016-5085(89)90081-4 · Cited by 2,085
Improvement by Acetylcysteine of Hemodynamics and Oxygen Transport in Fulminant Hepatic Failure
Harrison, P. M., Wendon, J. A., Gimson, A. E. S., Alexander, G. J. M., & Williams, R. (1991) · New England Journal of Medicine · doi:10.1056/nejm199106273242604 · Cited by 585
Alonso, A., Lau, J., Jaber, B. L., Weintraub, A., & Sarnak, M. J. (2004) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2003.09.009 · Cited by 345
Flagged first, then by citations
Research works printed but not linked: 24
- Lee, 1993, Medical progress: acute liver failure, N Engl J Med, 329, 1862, 10.1056/NEJM199312163292508 · DOI
- Polson, 2005, American Association for the Study of Liver Disease position paper: the management of acute liver failure, Hepatology, 41, 1179, 10.1002/hep.20703 · DOI
- Rakela, 1991, A double-blinded, randomized trial of hydrocortisone in acute hepatic failure, Dig Dis Sci, 36, 1223, 10.1007/BF01307513 · DOI
- Rake, 1971, Early and intensive therapy of intravascular coagulation in acute liver failure, Lancet, ii, 1215, 10.1016/S0140-6736(71)90540-X · DOI
- Harrison, 1990, Failure of insulin and glucagon infusions to stimulate liver regeneration in fulminant hepatic failure, J Hepatol, 10, 332, 10.1016/0168-8278(90)90141-D · DOI
- Sinclair, 1991, Treatment of fulminant viral hepatic failure with prostaglandin E, Dig Dis Sci, 36, 791, 10.1007/BF01311239 · DOI
- Ostapowicz, 2002, Results of a prospective study of acute liver failure at 17 tertiary care centers in the United States, Ann Intern Med, 137, 945, 10.7326/0003-4819-137-12-200212170-00007 · DOI · Paper page
- Prescott, 1983, The treatment of acetaminophen poisoning, Annu Rev Pharmacol Toxicol, 23, 87, 10.1146/annurev.pa.23.040183.000511 · DOI
- Hamlyn, 1978, The spectrum of paracetamol (acetaminophen) overdose: clinical and epidemiological studies, Postgrad Med J, 54, 400, 10.1136/pgmj.54.632.400 · DOI
- Rumack, 1984, Acetaminophen overdose in young children, Am J Dis Child, 138, 428, 10.1001/archpedi.1984.02140430006003 · DOI
- Makin, 1995, A 7-year experience of severe acetaminophen-induced hepatotoxicity (1987–1993), Gastroenterology, 109, 1907, 10.1016/0016-5085(95)90758-0 · DOI
- Walsh, 1998, The effect of N-acetylcysteine on oxygen transport and uptake in patients with fulminant hepatic failure, Hepatology, 27, 1332, 10.1002/hep.510270520 · DOI
- Rank, 2000, N-acetylcysteine increases liver blood flow and improves liver function in septic shock patients: results of a prospective, randomized, double-blind study, Crit Care Med, 28, 3799, 10.1097/00003246-200012000-00006 · DOI
- Schneider, 1994, In vivo evidence of enhanced guanylyl cyclase activation during the hyperdynamic circulation of acute liver failure, Hepatology, 19, 38, 10.1002/hep.1840190108 · DOI
- Zwingmann, 2006, Metabolic insights into the hepatoprotective effect of N-acetylcysteine in mouse liver, Hepatology, 443, 454, 10.1002/hep.21075 · DOI
- Hein, 2004, N-acetylcysteine decreases lactate signal intensities in liver tissue and improves liver function in septic shock patients, as shown by magnetic resonance spectroscopy: extended case report, Crit Care, 8, R66, 10.1186/cc2426 · DOI
- Sklar, 2004, Acetylcysteine treatment for non-acetaminophen-induced acute liver failure, Ann Pharmacother, 38, 498, 10.1345/aph.1D209 · DOI
- Davern, 2006, Measurement of serum acetaminophen-protein adducts in patients with acute liver failure, Gastroenterology, 130, 687, 10.1053/j.gastro.2006.01.033 · DOI · Paper page
- James, 2006, Detection of acetaminophen-protein adducts in children with acute liver failure of indeterminate cause, Pediatrics, 118, 676, 10.1542/peds.2006-0069 · DOI
- Wiesner, 2003, Model for end-stage liver disease (MELD) and allocation of donor livers, Gastroenterology, 124, 91, 10.1053/gast.2003.50016 · DOI
- Kremers, 2004, MELD score as a predictor of pre-transplant and posttransplant survival in OPTN/UNOS status 1 patients, Hepatology, 39, 764, 10.1002/hep.20083 · DOI
- Zaman, 2006, MELD score as a prognostic model for listing acute liver failure patients for liver transplantation, Transplant Proc, 38, 2097, 10.1016/j.transproceed.2006.06.004 · DOI
- Katoonizadeh, 2007, MELD score to predict outcome in adult patients with non-acetaminophen induced acute liver failure, Liver Int, 27, 329, 10.1111/j.1478-3231.2006.01429.x · DOI
- Kortsalioudaki, 2008, Safety and efficacy of N-acetylcysteine in children with non-acetaminophen-induced acute liver failure, Liver Transpl, 14, 25, 10.1002/lt.21246 · DOI
Cited by
Sorted by citations
EASL Clinical Practice Guidelines: Drug-induced liver injury
Andrade, R. J., Aithal, G. P., Björnsson, E. S., Kaplowitz, N., Kullak-Ublick, G. A., Larrey, D., & Karlsen, T. H. (2019) · Journal of Hepatology · doi:10.1016/j.jhep.2019.02.014 · Cited by 1,276
Bernal, W., & Wendon, J. (2013) · New England Journal of Medicine · doi:10.1056/nejmra1208937 · Cited by 1,169
Andrade, R. J., Chalasani, N., Björnsson, E. S., Suzuki, A., Kullak-Ublick, G. A., Watkins, P. B., Devarbhavi, H., Merz, M., Lucena, M. I., Kaplowitz, N., et al. (2019) · Nature Reviews Disease Primers · doi:10.1038/s41572-019-0105-0 · Cited by 924
ACG Clinical Guideline: the diagnosis and management of idiosyncratic drug-induced liver injury
Chalasani, N. P., Hayashi, P. H., Bonkovsky, H. L., Navarro, V. J., Lee, W. M., & Fontana, R. J. (2014) · American Journal of Gastroenterology · doi:10.1038/ajg.2014.131 · Cited by 860
Self-citationStravitz, R. T., & Lee, W. M. (2019) · The Lancet · doi:10.1016/s0140-6736(19)31894-x · Cited by 844
Self-citationDrug-Induced Acute Liver Failure: Results of a U.S. Multicenter, Prospective Study
Reuben, A., Koch, D. G., & Lee, W. M. (2010) · Hepatology · doi:10.1002/hep.23937 · Cited by 772
Self-citationIron Homeostasis and Ferroptosis in Human Diseases: Mechanisms and Therapeutic Prospects
Ru, Q., Li, Y., Chen, L., Wu, Y., Min, J., & Wang, F. (2024) · Signal Transduction and Targeted Therapy · doi:10.1038/s41392-024-01969-z · Cited by 724
ACG Clinical Guideline: Diagnosis and Management of Idiosyncratic Drug-Induced Liver Injury
Chalasani, N. P., Maddur, H., Russo, M. W., Wong, R. J., Reddy, K. R., & on behalf of the Practice Parameters Committee of the American College of Gastroenterology (2021) · American Journal of Gastroenterology · doi:10.14309/ajg.0000000000001259 · Cited by 430
Outcomes in Adults With Acute Liver Failure Between 1998 and 2013: An Observational Cohort Study
Reuben, A., Tillman, H., Fontana, R. J., Davern, T., McGuire, B., Stravitz, R. T., Durkalski, V., Larson, A. M., Liou, I., Fix, O., et al. (2016) · Annals of Internal Medicine · doi:10.7326/m15-2211 · Cited by 390
Self-citationAASLD practice guidance on drug, herbal, and dietary supplement–induced liver injury
Fontana, R. J., Liou, I., Reuben, A., Suzuki, A., Fiel, M. I., Lee, W., & Navarro, V. (2023) · Hepatology · doi:10.1002/hep.32689 · Cited by 340
Self-citationAcetaminophen-related Hepatotoxicity
Bunchorntavakul, C., & Reddy, K. R. (2013) · Clinics in Liver Disease · doi:10.1016/j.cld.2013.07.005 · Cited by 322
A Review of Acetaminophen Poisoning
Hodgman, M. J., & Garrard, A. R. (2012) · Critical Care Clinics · doi:10.1016/j.ccc.2012.07.006 · Cited by 314
Drug-induced liver injury: Asia Pacific Association of Study of Liver consensus guidelines
Devarbhavi, H., Aithal, G., Treeprasertsuk, S., Takikawa, H., Mao, Y., Shasthry, S. M., Hamid, S., Tan, S. S., Philips, C. A., George, J., et al. (2021) · Hepatology International · doi:10.1007/s12072-021-10144-3 · Cited by 181
Sundaram, V., & Björnsson, E. S. (2017) · Hepatology Communications · doi:10.1002/hep4.1088 · Cited by 138
Drug-induced liver injury: a clinical update
Ghabril, M., Chalasani, N., & Björnsson, E. (2010) · Current Opinion in Gastroenterology · doi:10.1097/mog.0b013e3283383c7c · Cited by 123
Management of Acute Liver Failure: Update 2022
Tujios, S., Stravitz, R. T., & Lee, W. M. (2022) · Seminars in Liver Disease · doi:10.1055/s-0042-1755274 · Cited by 117
Self-citationBiologic and checkpoint inhibitor‐induced liver injury: a systematic literature review
Shah, P., Sundaram, V., & Björnsson, E. (2020) · Hepatology Communications · doi:10.1002/hep4.1465 · Cited by 64
Chinese guideline for the diagnosis and treatment of drug-induced liver injury: an update
Mao, Y., Ma, S., Liu, C., Liu, X., Su, M., Li, D., Li, Y., Chen, G., Chen, J., Chen, J., et al. (2024) · Hepatology International · doi:10.1007/s12072-023-10633-7 · Cited by 62
Drug-induced liver injury: Diagnosis, management and the role of liver transplantation
Ozturk, N. B., Uskudar, E., Toruner, M. D., Simsek, C., & Gurakar, A. (2025) · Hepatology Forum · doi:10.14744/hf.2024.2024.0003 · Cited by 9
The contemporary epidemiology, causes, and management of drug-induced liver injury
Swanson, L., & Fontana, R. J. (2026) · Hepatology Communications · doi:10.1097/hc9.0000000000001011
Self-citation
Metadata
- Authors
- Lee, W. M., Hynan, L. S., Rossaro, L., Fontana, R. J., Stravitz, R. T., Larson, A. M., Davern, T. J., Murray, N. G., McCashland, T., Reisch, J. S., & Robuck, P. R.
- Venue
- Gastroenterology
- Publisher
- Elsevier BV
- Published
- 2009-09
- Volume
- 137
- Issue
- 3
- Pages
- 856-864.e1
- ISSN
- 0016-5085
- PMC
- PMC3189485
- Cited by
- 607
- References
- 3
- Language
- en
- Update notices
- erratum (2013-09-01)
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review